Shagun Singh: Great. Thank you so much for taking the question. Just, I guess, a follow-up on Hugo. One of your competitors recently showcased their surgical robot that had an invisible design and twin motion capabilities. I’m just wondering what your thoughts are on the competitive landscape? Do you see it as a rising tide? Or just how do you think about your technology offering versus competition? And then I was just wondering if it’s possible to get any more specific color on how October and November is shaping out? Thank you for taking the questions.
Geoff Martha: Well, I’ll ask — thanks for the question. I’m going to ask Mike to take the Hugo question and I’ll follow-up on that one.
Mike Marinaro: Thanks, Shagun. So we were very interested to see the latest developments from our competitor here relative to their program. And I’ll say that they were about as expected no surprises there. We continue to be very excited and optimistic about the differentiation of our program with an open console, with a modular design with the ability to have flexibility in terms of location or site of care, which is highly differentiated from what we heard there in their discussions, as well as what we see in the market today. And so we see that differentiation continue and the reasons that our customers like Hugo to continue to be differentiated reasons. More broadly speaking, though, the good news is that there continues to be just real interest in expanding the penetration of robotics across multiple fields in surgery.
And we’re seeing continued increase in procedural volumes on a quarter-on-quarter basis. And so it’s good news for the field as that interest grows. So we’re well positioned and the field continues to expand, which is a good story for Medtronic.
Geoff Martha: Yes, and just to build on that, I mean, we talked about — we call it robotics, but I would argue it’s broader than that. And this isn’t the first time we’re out to change the dynamics of an entire market. That’s what we’re doing in the spine market right now. And it goes beyond robotics. It gets into interoperative imaging or visualization navigation, presurgical, AI-based planning. And like with — and Mike’s role here with Hugo, we’ve got Touch Surgery Enterprise, which is a leading digital platform with AI-driven digital platform. And like you’re seeing in spine that’s played out over the last couple of years, it’s changing the competitive dynamics or what’s important in the marketplace for our physicians and even patients.
And you’re seeing the impact as what you’re seeing in the spine market as many competitors. It takes a lot of expertise. It takes a lot of capital to make this happen. And you’re seeing competitors fall by the wayside. And I know there’s been a big one here recently with NuVasive and Globus coming together, and we’ll see how that plays out. But I believe we’ve demonstrated an ability to do this. And this is the kind of experience. And I know we’re up against a big competitor in Intuitive in the surgical space, but we believe we’ve got a lot to offer here. And we are going to drive a change in how people think about the space and the competitive dynamics, and we’re really confident and excited about that. So with that, I think we’ll bring the call to close.
Thanks for sticking with us a little longer. And I really appreciate the questions and the support and continued interest in Medtronic. And we look forward to updating you on our continued progress on our Q3 earnings broadcast, which we anticipate holding on Tuesday, February 20. With that, thanks for joining us today. And for those in the U.S., I’d like to wish you and your families a very happy Thanksgiving this week and enjoy the holiday and stay safe. Thank you.
